Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting

BACKGROUND: The evidence base of tisagenlecleucel is uncertain. OBJECTIVE: To evaluate the cost-effectiveness of tisagenlecleucel. To conduct expected value of perfect information (EVPI) and partial EVPI (EVPPI) analyses. STUDY DESIGN: A three-state partitioned survival model. A short-term decision...

Descripción completa

Detalles Bibliográficos
Autores principales: Carey, Niamh, Leahy, Joy, Trela-Larsen, Lea, Mc Cullagh, Laura, Barry, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858398/
https://www.ncbi.nlm.nih.gov/pubmed/36684853
http://dx.doi.org/10.1080/20016689.2023.2166375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858398/
https://www.ncbi.nlm.nih.gov/pubmed/36684853
http://dx.doi.org/10.1080/20016689.2023.2166375

Ejemplares similares